Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly nonalcoholic fatty liver disease (NAFLD), is common with type 2 diabetes and obesity. Potentially more than 70% of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results